The abstract is read at the publisher; the summary is JClub's.
Undiagnosed chronic kidney disease is prevalent in high-risk patients with heart failure enrolled in the FINEARTS-HF randomized clinical trial, and it is linked to cardiovascular outcomes.
- Why it matters: Heart failure patients are at high risk for kidney impairment, but the prevalence and outcome relevance of undiagnosed chronic kidney disease are unclear.
- What they did: This secondary analysis of the FINEARTS-HF randomized clinical trial assessed how often undiagnosed chronic kidney disease occurs and tested its association with cardiovascular outcomes.
- The result: The findings support using undiagnosed chronic kidney disease status to better interpret cardiovascular risk in this heart failure population and inform finerenone-related evaluation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.